Skip to main content

Table 3 Main intention to treat analyses of effect of Walk Well programme on primary and secondary outcomes assessed immediately after end of programme (12 weeks)

From: Process evaluation of the Walk Well study: a cluster-randomised controlled trial of a community based walking programme for adults with intellectual disabilities

 

Walk Well

Control

Main between group comparison

Outcomes

N

Mean (SD)

N

Mean (SD)

Mean difference at 12-weeks (95 % CI)a

p

ICC

Primary outcome

       

Step count per day

42

4823 (2059)

40

4784 (2613)

69.5 (-1054 , 1193.3)

0.90

0.51

Secondary outcomes

       

Percentage time per day MVPA

42

3.0 (2.6)

40

3.1 (2.1)

0.3 (-0.7 , 1.3)

0.55

0.42

Percentage time per day sedentary

42

66.4 (10.0)

40

65.9 (12.0)

1.6 (-3.0 , 6.1)

0.49

0.22

Total MET minutes per week

37

1311.9 (1293.2)

37

1154.8 (1103.7)

56.0 (-428.8,540.9)

0.82

0.02

Body Mass Index (kg/m2)

43

32.1 (7.7)

43

32.9 (7.5)

−0.2 (-0.83,0.41)

0.49

0.00

Waist circumference (cm)

45

104.9 (16.9)

42

107.8 (17.8)

−1.6 (-3.93,0.64)

0.15

0.00

Subjective vitality (mean score)

39

14.6 (2.5)

35

14.3 (2.8)

0.3 (-0.85, 1.52)

0.57

0.00

Self-efficacy (mean score)

43

14.4 (3.0)

42

13.7 (3.7)

0.8 (-0.68, 2.22)

0.29

0.08

EQ-5D (mean health utility score)

44

0.8 (0.27)

43

0.7 (0.30)

0.0 (-0.09, 0.14)

0.70

0.00

  1. SD standard deviation, ICC intraclass correlation coefficient, EQ-5D European quality of Life 5 Dimensions, MET metabolic equivalents, MVPA moderate vigorous physical activity; aBetween group mixed effects model adjusted for cluster and baseline value